Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Human Hypertension|August 1, 1995
Ethnic origin and hypertension-associated alterations in sodium-lithium countertransport kineticsT C Hardman, P Croft, R Barlow, et al.Journal of Inherited Metabolic Disease|March 10, 1999
Transport of phytanic acid on lipoproteins in Refsum diseaseA S Wierzbicki, A Sankaralingam, P J Lumb, et al.BMJ (Clinical Research Ed.)|July 25, 1992
Erythrocyte sodium-lithium countertransport and blood pressure in identical twin pairs discordant for insulin dependent diabetesT C Hardman, S W Dubrey, D G Leslie, et al.European Journal of Clinical Pharmacology|April 11, 2001
Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitorK H Moore, L M Cass, N Dallow, et al.Journal of Clinical Pharmacology|October 5, 2001
Pharmacokinetics and tolerability of GW420867X, a nonnucleoside reverse transcriptase inhibitor, following single escalating doses in healthy male volunteersK H Moore, L M Cass, N Dallow, et al.American Journal of Hypertension|February 24, 2001
Relation between sodium-lithium countertransport and hypertriglyceridemia in type V hyperlipidemiaA S Wierzbicki, T C Hardman, J Cheung, et al.European Journal of Clinical Investigation|June 6, 1998
Influence of plasma phytanic acid levels in Refsum's disease on the behaviour of the erythrocyte membrane sodium-lithium countertransporterA S Wierzbicki, T C Hardman, P Lumb, et al.Journal of Human Hypertension|September 12, 2000
Effects of lipids in patients with familial hypercholesterolaemia on the kinetics of the sodium-lithium countertransporterA S Wierzbicki, T C Hardman, J Cheung, et al.Pageof 2